Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Zolbetuximab-clzb (Vyloy) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Vulvectomy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Viltolarsen (Viltepso) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Verteporfin (Visudyne) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Velaglucerase Alfa (VPRIV) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Urinary Metabolite Tests for Adherence to Direct-Acting Antiviral Medications for Hepatitis C | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Upper Limb Myoelectric Orthosis | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Triptorelin (Triptodur) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Triamcinolone Acetonide Injectable Suspension (Xipere) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Triptorelin Pamoate (Trelstar) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Transvaginal and Transurethral Radiofrequency Tissue Remodeling for Urinary Stress Incontinence | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Transcranial Magnetic Stimulation (TMS) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Trabectedin (Yondelis, Evdi) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Total Artificial Heart (TAH) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Tisotumab Vedotin-tftv (Tivdak) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Treatment of Tinnitus | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Thyrotropin Alfa (Thyrogen) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Transpupillary Thermotherapy (TTT) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Thermography | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Tezepelumab-ekko (Tezspire) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Tislelizumab-jsgr (Tevimbra) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Testosterone Product: (Testosterone Pellets [Testopel]) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Teplizumab-mzwv (Tzield) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Teprotumumab-trbw (Tepezza) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Temsirolimus (Torisel) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Temozolomide (Temodar) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Teclistamab-cqyv (Tecvayli) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Talquetamab-tgvs(Talvey) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Treatments for Athletic Groin Pain | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Stem Cell Therapy for Peripheral Artery Disease | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Ustekinumab Products: Ustekinumab (Stelara); Ustekinumab-auub (Wezlana); Ustekinumab-srlf (Imuldosa); Ustekinumab-aauz (Otulfi); Ustenkinumab-ttwe (Pyzchiva), Ustekinumab-aekn (Selarsdi); Ustenkinumab-stba (Steqeyma); Ustenkinumba-kfce (Yesintek); ustekinumab; ustekinumab-aauz, ustekinumab-stba, ustekinumab-aekn ; ustenkinumab-ttwe; Ustekinumab-hmny (Starjemza) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Spesolimab-sbzo (Spevigo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Sotatercept-csrk (Winrevair) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Siltuximab (Sylvant) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Signal Averaged Electrocardiography (SAECG) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Zoster Vaccine Recombinant, Adjuvanted | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Saturation Biopsy for Diagnosis and Staging of Prostate Cancer | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Sacituzumab Govitecan-hziy (Trodelvy) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Rozanolixizumab‐noli (Rystiggo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Romidepsin [Istodax; Romidepsin (liquid)] | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Valoctocogene Roxaparvovec‐rvox (Roctavian) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Oncology Indications) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Rituximab Products (Rituxan, Rituximab-abbs [Truxima],Rituximab-arrx [Riabni] and Rituximab-pvvr [Ruxience]) (Non-Oncology Indications) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Rituximab and Hyaluronidase Human Injection (Rituxan Hycela) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Risankizumab-rzaa (Skyrizi) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Rhinoplasty | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Retinal Telescreening for Diabetic Retinopathy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Retifanlimab-dlwr (Zynyz) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Remestemcel-L-rknd (Ryoncil) | Criteria changed |